Breakdown
13 January 2014

U.S. drug wholesaler McKesson has failed to buy its German peer – despite both sides and most shareholders wanting a deal. The drawn-out process exposed weaknesses at Celesio and in Germany’s M&A rules. Elliott, the hedge fund that tried to play kingmaker, will suffer too.